Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Showing 20 of 0 results

Not applicableStudy completedNCT04135300
What this trial is testing

Gene Therapy for Chinese Hemophilia B

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableUnknownNCT02512211
What this trial is testing

Validation of Questionnaires HAL and HEP

Who this might be right for
Haemophilia
Universidad Católica San Antonio de Murcia 60
Not applicableStudy completedNCT02740413
What this trial is testing

Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Who this might be right for
Hemophilia AHemophilia B
Pfizer 86
Not applicableStudy completedNCT02528968
What this trial is testing

National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A

Who this might be right for
Hemophilia A
Hampshire Hospitals NHS Foundation Trust 59
Not applicableStudy completedNCT06234813
What this trial is testing

Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study

Who this might be right for
Glanzmann Thrombasthenia
University Hospital, Bordeaux 20
Not applicableStudy completedNCT05449197
What this trial is testing

Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in France

Who this might be right for
Hemophilia A
Hospices Civils de Lyon 363
Large-scale testing (Phase 3)Study completedNCT02065882
What this trial is testing

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Who this might be right for
Congenital AfibrinogenemiaCongenital Hypofibrinogenemia
Biotest 67
Not applicableStudy completedNCT02634723
What this trial is testing

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 21
Not applicableStudy completedNCT02368340
What this trial is testing

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Who this might be right for
Hermansky Pudlak Syndrome
Vanderbilt University 55
Not applicableStudy completedNCT00344435
What this trial is testing

Genetic Susceptibility to Factor VIII Inhibitors

Who this might be right for
Hemophilia
National Cancer Institute (NCI) 1,187
Large-scale testing (Phase 3)Study completedNCT03879135
What this trial is testing

Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

Who this might be right for
Von Willebrand Disease (VWD)
Baxalta now part of Shire 38
Not applicableUnknownNCT04279717
What this trial is testing

Latin-American Von Willebrand Disease Registry

Who this might be right for
Von Willebrand Disease
Academia Nacional de Medicina 500
Early research (Phase 1)Study completedNCT02483208
What this trial is testing

Single Dose Study in Subjects With Severe Hemophilia A Comparing Pharmacokinetic Parameters for BAY81-8973 and Advate

Who this might be right for
Hemophilia A
Bayer 18
Testing effectiveness (Phase 2)Ended earlyNCT02267408
What this trial is testing

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Who this might be right for
Hypoprothrombinemia
McMaster University 42
Not applicableActive Not RecruitingNCT06883240
What this trial is testing

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Who this might be right for
Von Willebrand Disease, Type 3
Hoffmann-La Roche 44
Not applicableStudy completedNCT00640289
What this trial is testing

Clinical Trial of Factor XIII (FXIII) Concentrate

Who this might be right for
HemophiliaFactor XIII Deficiency
Children's Hospital of Orange County 72
Not applicableStudy completedNCT05028894
What this trial is testing

23andMe IPF Research Study

Who this might be right for
Idiopathic Pulmonary Fibrosis
23andMe, Inc. 690
Early research (Phase 1)Study completedNCT05681845
What this trial is testing

Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge

Who this might be right for
Haemophilia A
Novo Nordisk A/S 205
Post-approval studies (Phase 4)Ended earlyNCT00765726
What this trial is testing

Study Evaluating The Safety Of Xyntha In Usual Care Settings

Who this might be right for
Hemophilia A
Pfizer 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06922045
What this trial is testing

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

Who this might be right for
Hemophilia
Jiangsu BioJeTay Biotechnology Co., Ltd. 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation